Temozolomide Challenge After Progressive disease
- Conditions
- malignant glioma
- Registration Number
- JPRN-UMIN000014688
- Lead Sponsor
- Department of Neurosurgery Ehime University Graduated School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 39
Not provided
1)Patients with a history of hypersensitivity to dacarbazine or temozolomide. 2)Patients who are contraindicated to chemotherapeutic agents other than temozolomide. 3)The patient in need of surgery, additional radiotherapy to the PD after determination 4)Pregnant or lactating women 5)Double cancer of activity 6)It is complicated by pneumonia or meningitis in need of treatment. 7)Has been complicated by psychiatric symptoms or psychosis, it is determined that participation in the research is difficult. 8)patients have been complicated by uncontrolled diabetes. 9)patients have unstable angina or a history of myocardial infarction within 3 months. 10)And has a history of interstitial pneumonia or pulmonary fibrosis,. 11)When used interferon beta preparation maintenance therapy by temozolomide, patients corresponding to the following items are excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method